Form 4: Rocket Lab CFO Sells $103M in RKLB Stock

Rocket Lab's Chief Financial Officer, Adam Spice, executed a pre-planned sale of over 1.3 million shares of company stock, totaling approximately $103.12 million, after exercising options.

Summary

• Adam Spice, Chief Financial Officer of Rocket Lab Corp (RKLB), engaged in significant stock transactions on January 5, 2026.
• He acquired 731,330 shares of common stock by exercising employee stock options at a price of $1.09 per share.
• Subsequently, he sold a total of 1,365,665 shares of common stock through multiple transactions.
• The sales were executed at weighted-average prices ranging from $72.149 to $78.0435 per share.
• The total value of shares sold amounted to approximately $103.12 million.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on September 19, 2025.
• Following these transactions, Adam Spice directly beneficially owns 1,359,568 shares of common stock and 2,522,825 employee stock options.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the substantial insider selling by a key executive. While the sales were pre-planned under a 10b5-1 plan, the sheer volume and value of the divestment can still be perceived as a lack of strong conviction in the company's future stock price performance by an insider.

Positives

• The CFO exercised options at a very low price ($1.09) compared to the market sale prices (ranging from $72.149 to $78.0435), indicating significant personal profit.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests the sales were not based on new, non-public information.

Negatives

• Significant insider selling by a key executive (CFO) could be perceived negatively by investors, potentially signaling a lack of confidence in future stock price appreciation, despite the 10b5-1 plan.
• The total value of shares sold, over $103 million, represents a substantial divestment.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the significant insider selling as a negative signal, potentially impacting investor confidence and stock price.

Key Dates

Recommendation

While the significant insider selling by the CFO is a notable event, it was conducted under a pre-arranged 10b5-1 plan, which mitigates the immediate negative signal compared to unplanned sales. The executive still retains a substantial number of shares and options. Investors should monitor future company performance and broader market conditions for Rocket Lab rather than making an immediate 'sell' decision based solely on this pre-planned transaction. A 'hold' recommendation allows for further evaluation without overreacting to a planned liquidity event.

Keywords

Rocket Lab, RKLB, Adam Spice, CFO, insider trading, Form 4, stock sale, option exercise, 10b5-1 plan, equity compensation, space industry